Fig. 6From: A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetesFrequency of patients with investigator-reported hypoglycaemia (treated set). BG blood glucoseBack to article page